DRTS · US market
ALPHA TAU MEDICAL LTD ORDINARY SHARES
Compare this company’s P/E and P/S using trailing results and the latest quarter. Ratios are calculated here from market capitalisation, signed ordinary or common-shareholder earnings and revenue.
Market cap US$1.28bnFinancials dated 31 December 2025Price dated 1 October 2026
Core valuation
* P/E uses the latest reported full year ended 31 December 2025 because neither a trailing four-quarter value nor a latest-quarter value is available.
Calculation inputs
- Trailing earnings
- Unavailable
- Latest-quarter run-rate earnings
- Unavailable
- Latest fiscal-year earnings
- -US$42.63m
- Trailing revenue
- Unavailable
- Latest-quarter run-rate revenue
- Unavailable
- Latest fiscal-year revenue
- Unavailable
Featured ETF and mutual-fund exposure
These public funds report this company in their latest disclosed holdings.
- IZRL · ARK Israel Innovative Technology ETF1.66% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- DNDGX · Dunham Small Cap Growth Fund Class N0.26% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- FNCMX · Fidelity NASDAQ Composite Index Fund0.00% weight · Holdings dated 31 May 2026
Sources and limitations
Financial inputs are attributed to SEC EDGAR. Market cap is calculated locally where auditable price and share inputs are available. Missing data stays missing; losses are retained as signed values and produce a numeric signed P/E.
Open financial sourceFinancials as of 31 December 2025. Informational research, not investment advice.